Merck KGaA (FRA:MRK) received a €118.00 ($124.21) price objective from analysts at Deutsche Bank AG in a report issued on Wednesday. The brokerage presently has a “buy” rating on the stock.

MRK has been the topic of a number of other research reports. Warburg Research set a €103.10 ($108.53) price objective on Merck KGaA and gave the stock a “buy” rating in a research report on Thursday, August 4th. equinet AG set a €85.00 ($89.47) price objective on Merck KGaA and gave the stock a “buy” rating in a research report on Thursday, August 4th. DZ Bank AG restated a “buy” rating on shares of Merck KGaA in a research report on Friday, August 5th. Commerzbank AG set a €101.00 ($106.32) price objective on Merck KGaA and gave the stock a “buy” rating in a research report on Tuesday, August 30th. Finally, Credit Suisse Group AG set a €108.00 ($113.68) price objective on Merck KGaA and gave the stock a “buy” rating in a research report on Friday, August 5th. One investment analyst has rated the stock with a sell rating, twelve have assigned a hold rating and ten have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of €102.28 ($107.66).

Analyst Recommendations for Merck KGaA (FRA:MRK)

Shares of Merck KGaA (FRA:MRK) opened at 95.638 on Wednesday. The stock’s 50 day moving average price is €95.30 and its 200-day moving average price is €93.78. The firm has a market cap of €41.63 billion and a price-to-earnings ratio of 27.973. Merck KGaA has a 52-week low of €70.87 and a 52-week high of €100.00.

COPYRIGHT VIOLATION WARNING: This report was first posted by Financial Market News and is owned by of Financial Market News. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international copyright laws. The legal version of this report can be read at http://www.financial-market-news.com/merck-kgaa-mrk-given-a-118-00-price-target-at-deutsche-bank-ag/1210243/.

About Merck KGaA

.

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.